What does a hereditary angioedema (HAE) attack look like? An HAE attack can cause swelling of body parts such as the extremities and a red rash that may look like hives.

Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...

Hereditary angioedema (HAE) is a genetic disorder that causes sudden episodes of swelling, often accompanied by abdominal pain. Affecting roughly 1 in 50 000 people, HAE typically appears in childhood ...

Identification and segmentation of tumors from CT scans are essential for early detection and effective treatment but they remain challenging due to imaging artifacts and significant variability in ...

Objective Helicobacter pylori is associated with gastric inflammation, precancerous gastric atrophy (GA) and intestinal metaplasia (IM). We aimed to identify microbes that are associated with ...

The smallest species of whale tricks its predators by gushing gallons of red fluid into the water when under attack.

The totality of bacteria, viruses and fungi that exist in and on a multicellular organism forms its natural microbiome. The interactions between the body and these microorganisms significantly ...

Research carried out on mice has revealed how a hormone released by the intestine acts on the brain and helps regulate the body's energy expenditure. FGF19 (fibroblast growth factor 19) activates ...

Study finds abdominal fat causes more blood vessel harm than subcutaneous fat by German Centre for Cardiovascular Research (DZHK) edited by Sadie Harley, reviewed by Andrew Zinin Editors' notes ...

The clinical spectrum of intestinal E. histolytica infection ranges from an asymptomatic carrier state to severe invasive disease. Asymptomatic cyst carriage occurs with E. histolytica as well as ...

The approval of Andembry is for use in adult and pediatric patients aged 12 years and older and is self-administered with once-monthly dosing delivered in 15 seconds or less via an autoinjector ...

FRIDAY, June 20, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent ...